Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BD Combinations of oral blood glucose lowering drugs
A10BD10 Metformin and saxagliptin
D10263 Metformin hydrochloride and saxagliptin hydrochloride <US>
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Combinations
Metformin Hydrochloride/ Saxagliptin
D10263 Metformin hydrochloride and saxagliptin hydrochloride
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG03032 Combination of metformin and DPP-4 inhibitor
D10263 Metformin hydrochloride and saxagliptin hydrochloride
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10263 Metformin hydrochloride and saxagliptin hydrochloride
DG02925 CYP3A5 substrate
D10263 Metformin hydrochloride and saxagliptin hydrochloride
Drug classes [BR:br08332]
Antidiabetic agent
DG02044 Hypoglycemic agent
D10263 Metformin hydrochloride and saxagliptin hydrochloride
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10263
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10263